This inventor holds 4 USPTO granted patents. Top assignees: Jiangsu Kanion Pharmaceutical Co., Ltd., Jiangsu Kanion Pharmaceutical Co., Ltd.. Active years: 2025-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025-2026
Title: The Innovative Contributions of Liang Cao
Introduction
Liang Cao is a notable inventor based in Lianyungang, China. He has made significant contributions to the field of traditional Chinese medicine, particularly in the context of modern health challenges. His work focuses on developing innovative solutions for treating and preventing diseases, including those caused by viral infections.
Latest Patents
Liang Cao holds a patent for the "Application of traditional Chinese medicine composition to preparation of medicine for treating or preventing coronavirus infection." This patent highlights a traditional Chinese medicine composition that includes various herbal components, specifically designed to combat coronavirus-related diseases. The formulation consists of 5-30 parts of specific ingredients, demonstrating a thoughtful approach to integrating traditional practices with contemporary medical needs. This innovative composition has shown promising effects in treating or preventing infections related to the coronavirus.
Career Highlights
Cao is associated with Jiangsu Kanion Pharmaceutical Co., Ltd., where he applies his expertise in traditional medicine to develop effective treatments. His work at the company reflects a commitment to advancing healthcare solutions through the integration of traditional knowledge and modern science.
Collaborations
Liang Cao collaborates with talented individuals such as Zhenzhen Su and Zhipeng Ke, who contribute to his research and development efforts. Their teamwork enhances the potential for innovative breakthroughs in the field of medicine.
Conclusion
Liang Cao's contributions to traditional Chinese medicine and his innovative patent for treating coronavirus infections underscore the importance of integrating traditional practices with modern medical challenges. His work exemplifies the potential of innovation in addressing global health issues.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile